Pharmaceutical industry – Page 19
-
NewsUS chemical plants risk disastrous cyberattacks relying on guidance a decade out of date
Cybersecurity guidelines for chemical plants urgently need updating and inspectors need training, report finds
-
BusinessHow Covid-19 is changing drug manufacturing
Catalent is adapting, focusing on employee safety and supply chain security
-
BusinessThis little Crispr went to market
Gene editing technology heading towards commercial reality in pharmaceuticals, food and organ transplant
-
OpinionHopes and fears for remdesivir
Available resources for testing coronavirus treatments need to be used wisely
-
OpinionDoes the drug work, or not?
Coronavirus trials reveal the murky reality of disentangling compounds’ effects on human biology
-
BusinessMicropore Technologies’ model membranes make exact emulsions
Solving scalability issues to control particle size without high-shear mixing
-
-
BusinessPostEra points its synthesis algorithm at coronavirus
Mapping out drug discovery routes with artificial intelligence
-
BusinessMystery surrounds UK claim of Covid-19 test reagent ‘shortage’
Suppliers are stepping up production to meet demand as UK targets mass testing
-
OpinionVaccine development against the clock
How long will it take to develop a coronavirus vaccine and why is it so hard?
-
BusinessCan existing drugs slow Covid-19?
The fastest route to treatments may be to repurpose existing drugs – if they work
-
BusinessGetting ideas across
In a diverse industry like chemicals, we need to make sure we’re open to learning from unexpected angles.
-
OpinionTime for industry to show its humanity
Companies need to demonstrate community spirit in the face of the coronavirus pandemic
-
BusinessData is lacking as Reach moves beyond registration
Enforcing the demanding rules of Europe’s chemical legislation is keeping regulators and companies on their toes
-
OpinionWhy picking projects is like poker
Sometimes you prefer the high-risk, high-reward project to the ‘sure thing’
-
BusinessFDA freezes foreign facility inspections amid coronavirus pandemic
US regulator will rely on border checks and shared data, but some approval processes may be delayed
-
BusinessCoronavirus pandemic will disrupt international supply chains
Halted production and transport restrictions are straining industries that rely heavily on China for supplies
-
BusinessRNA vaccines are coronavirus frontrunners
Several groups have potential Sars-CoV-2 vaccines ready or close to testing, thanks to rapid development pathways
-
OpinionTwo heads are better than one
Bifunctionals show that sometimes simply tethering two useful molecules together unlocks some useful activity
-
NewsNumber of industrial chemicals being produced globally grossly underestimated
Analysis of national chemical inventories finds three times as many chemicals registered for production as previously thought